NASDAQ:NTRB Nutriband Q4 2025 Earnings Report $8.13 +0.48 (+6.27%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$8.28 +0.15 (+1.89%) As of 09/18/2026 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Nutriband EPS ResultsActual EPS-$0.18Consensus EPS -$0.12Beat/MissMissed by -$0.06One Year Ago EPSN/ANutriband Revenue ResultsActual Revenue$0.64 millionExpected Revenue$0.71 millionBeat/MissMissed by -$70.00 thousandYoY Revenue GrowthN/ANutriband Announcement DetailsQuarterQ4 2025Date4/28/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsNutriband's next earnings date is estimated for Wednesday, September 30, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Nutriband Earnings HeadlinesNutriband CEO Gareth Sheridan to Attend Inaugural Nasdaq LaB Biotech SummitSeptember 9, 2026 | quiverquant.comQNutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech SummitSeptember 9, 2026 | globenewswire.comA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks. | TradeSmith (Ad)Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl PatchSeptember 8, 2026 | globenewswire.comNutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO SpotlightAugust 13, 2026 | globenewswire.comNutriband shareholders approve proposals and expand board leadershipJune 23, 2026 | theglobeandmail.comSee More Nutriband Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Nutriband? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nutriband and other key companies, straight to your email. Email Address About NutribandNutriband (NASDAQ:NTRB) is a medical technology company that develops, manufactures and commercializes transdermal and topical delivery products. Its technologies are designed to deliver medications or other active ingredients through the skin using adhesive patches and related wearable formats. The company offers product development and manufacturing services for prescription, over-the-counter, consumer health and cosmetic applications. Its portfolio includes transdermal patches and other topical delivery systems, with products intended for areas such as pain management, wellness and pharmaceutical drug delivery. Nutriband also develops its AVERSA technology, a platform designed to help deter the abuse and misuse of transdermal medications by incorporating deterrent components into patches. The company serves pharmaceutical, healthcare and consumer-product partners and is based in Orlando, Florida.View Nutriband ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in FocusPriced for a Pullback or More Gains? These 3 Stocks Are Testing the LimitsCoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
